You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

74 search results for: asthma

ERS 2024 | Pediatric Severe <b>Asthma</b>: Is Clinical Remission Possible?
expert video

ERS 2024 | Pediatric Severe Asthma: Is Clinical Remission Possible?

Pulmonology
Watch as Leonard Bacharier, MD, and Sharon Dell, MD, FRCPC, discuss the concept of clinical remission in pediatric severe asthma.
View more
ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe <b>Asthma</b>?
Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Pulmonology
Join Drs. Len Bacharier and Sharon Dell as they highlight the natural course of pediatric asthma progression over time.
View more
Role of Type 2 Cytokines in <b>Asthma</b> and COPD
expert video

Role of Type 2 Cytokines in Asthma and COPD

Type 2 Inflammation
Dr Mario Castro explains how type 2 cytokines play a crucial role in airway remodeling and inflammation in asthma and COPD, impacting patient outcomes.
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With <b>Asthma</b>
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
ATS 2024 | Type 2 Inflammation in the Pathophysiology of <b>Asthma</b> and COPD: What Is It and How Does It Impact Patients?
expert video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Pulmonology
Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.
View more
ERS 2024 | How Can Biologics Help Achieve Clinical Remission in Children With Severe <b>Asthma</b>?
expert video

ERS 2024 | How Can Biologics Help Achieve Clinical Remission in Children With Severe Asthma?

Pulmonology
In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Sharon Dell highlights the available clinical biologic efficacy data in pediatric severe asthma, suggesting the potential for achieving clinical remission when added to an asthma management plan.
View more
ERS 2024 | Panel Discussion: What Might Be Required for On-Therapy Remission in Pediatric Severe <b>Asthma</b>?
expert video

ERS 2024 | Panel Discussion: What Might Be Required for On-Therapy Remission in Pediatric Severe Asthma?

Pulmonology
In this ADVENT symposium at the 2024 European Respiratory Society conference, Drs. Sharon Dell and Leonard Bacharier discuss the potential domains of on therapy clinical remission in pediatric severe asthma, emphasizing lung function as a key parameter for children.
View more
Type 2 Inflammation Is a Significant Driver of Pediatric Severe <b>Asthma</b>
Infographic

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

Pulmonology
Learn about the role of type 2 inflammation in the burden and pathophysiology of severe asthma in pediatric patients
View more
Monitoring Lung Function Is an Important Aspect of Pediatric <b>Asthma</b> Management
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

Pulmonology
Navigate through this interactive infographic to learn more about why lung function is important to monitor in pediatric patients with asthma and the noninvasive procedures that are available for implementation in clinical practice.
View more
ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe <b>Asthma</b> – Patient Case Introduction
expert video

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Introduction

Pulmonology
In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Leonard Bacharier describes a typical patient presentation in the pediatric asthma clinic and explores whether clinical remission is a goal of treatment for this patient and others like them.
View more
ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe <b>Asthma</b> – Patient Case Follow-Up
expert video

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Follow-Up

Pulmonology
In this ADVENT symposium at the 2024 European Respiratory Society conference, Dr. Leonard Bacharier revisits a patient case study where a biologic has been added to an asthma management plan and describes the potential for this patient to achieve on-therapy clinical remission.
View more
ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe <b>Asthma</b> With Spirometry and Beyond
Podcast

ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond

Pulmonology
Join Drs. Wanda Phipatanakul and Theresa Guilbert as they discuss the importance of routine lung function assessment in pediatric asthma patients.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: SudanChange country/region